KURA

Kura Oncology, Inc. Common Stock

$12.00 -$0.40 -3.33%



Shares Bought5
Shares Sold5
Total10
Shares Owned0
Last Price$12.00
Total Return$6.05
Range Today$11.70 - $12.47
52 Week Range$4.00 - $13.80
Open$12.40
Market Cap$239.86M
Volume/Average154.81K/211.60K
P/E Ratio-
Dividend/Yield-




Kura Oncology, Inc. is a clinical-stage biopharmaceutical company engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.


Orders

Date Side Shares Price
09-08-2017 14:00:47 buy 1 $10.75
09-08-2017 14:02:37 buy 1 $11.00
09-08-2017 14:03:16 buy 1 $10.90
09-08-2017 14:31:11 sell 1 $12.75
09-08-2017 14:33:18 sell 1 $12.95
09-08-2017 17:26:14 sell 1 $12.85
09-13-2017 15:06:41 buy 1 $11.95
09-13-2017 15:14:55 buy 1 $11.80
09-14-2017 15:20:09 sell 1 $12.00
09-14-2017 15:31:51 sell 1 $11.90